Literature DB >> 10737369

Molecular biology of esophageal squamous cell carcinoma.

A K Lam1.   

Abstract

Esophageal squamous cell carcinoma (ESCC) is the predominant histologic subtype of esophageal cancer and characterized by high mortality rate and geographic differences in incidence. With the advances in the field of molecular biology, our understanding of the pathogenesis, epidemiology and behavior of ESCC continues to evolve. The recent development includes research in etiopathogenesis (viruses and cancer susceptibility genes), keratins, tumor related genes (oncogenes, tumor suppressor genes, genes involved in metastasis and apoptosis genes), proliferation-related factors (nuclear proteins, flow cytometry/morphometry, argyrophilic nucleolar organizer region) and factors related to metastases (cell adhesion molecules and enzymes related to degradation of extracellular matrix). There are ranges of molecular techniques potentially available to complement the traditional approaches in the management of ESCC. On the other hand, critics are needed in the interpretation and translation of these research findings from laboratories to clinics. Further investigations, education and collaborations between the various scientific and clinical disciplines are important to successful application of these molecular findings aiming at improving management of patients with ESCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737369     DOI: 10.1016/s1040-8428(99)00054-2

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  43 in total

1.  Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques.

Authors:  Marilanda Ferreira Bellini; Ana Elizabete Silva; Marileila Varella-Garcia
Journal:  Genet Mol Biol       Date:  2010-06-01       Impact factor: 1.771

2.  Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients.

Authors:  Noushin Taghavi; Firouzeh Biramijamal; Masoud Sotoudeh; Omeed Moaven; Hooman Khademi; Mohammad Reza Abbaszadegan; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

3.  Tiam1 siRNA enhanced the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo.

Authors:  Huaimin Liu; Xin Wang; Guirong Shi; Lifeng Jiang; Xiaoli Liu
Journal:  Tumour Biol       Date:  2014-05-23

4.  LncRNA DUXAP10 modulates cell proliferation in esophageal squamous cell carcinoma through epigenetically silencing p21.

Authors:  Zhongqiu Wang; Binhui Ren; Jianfeng Huang; Rong Yin; Feng Jiang; Qin Zhang
Journal:  Cancer Biol Ther       Date:  2018-09-14       Impact factor: 4.742

Review 5.  Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.

Authors:  Yasushi Sasaki; Miyuki Tamura; Ryota Koyama; Takafumi Nakagaki; Yasushi Adachi; Takashi Tokino
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

6.  Clinical impact of predicting CCND1 amplification using plasma DNA in superficial esophageal squamous cell carcinoma.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Shoji Hirajima; Hiroki Takeshita; Atsushi Shiozaki; Hitoshi Fujiwara; Tsutomu Kawaguchi; Mahito Miyamae; Hirotaka Konishi; Takeshi Kubota; Kazuma Okamoto; Nobuaki Yagi; Eigo Otsuji
Journal:  Dig Dis Sci       Date:  2014-01-24       Impact factor: 3.199

Review 7.  Chemoprevention of esophageal squamous cell carcinoma.

Authors:  Gary D Stoner; Li-Shu Wang; Tong Chen
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-15       Impact factor: 4.219

8.  Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area.

Authors:  Irfana Salam; Showket Hussain; Mohammad Muzaffar Mir; Nazir Ahmad Dar; Safiya Abdullah; Mushtaq Ahmad Siddiqi; Riyaz Ahmad Lone; Showkat Ahmad Zargar; Shashi Sharma; Suresh Hedau; Seemi Farhat Basir; Alok Chandra Bharti; Bhudev C Das
Journal:  Mol Cell Biochem       Date:  2009-06-10       Impact factor: 3.396

9.  Elevated serum levels of human relaxin-2 in patients with esophageal squamous cell carcinoma.

Authors:  Peng Ren; Zhen-Tao Yu; Li Xiu; Mei Wang; Hua-Min Liu
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

10.  Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma.

Authors:  H Takeshita; D Ichikawa; S Komatsu; M Tsujiura; T Kosuga; K Deguchi; H Konishi; R Morimura; A Shiozaki; H Fujiwara; K Okamoto; E Otsuji
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.